摘要
目的:探讨SEA0400对离体大鼠心肌细胞缺血再灌注损伤的保护作用及其机制。方法:利用酶解法分离成年Wistar大鼠心脏获得心肌细胞悬液,随机分成3组进行研究:(1)对照组:心肌细胞用再灌注液培养60min,未经历缺血再灌注过程;(2)缺血再灌注损伤组:心肌细胞缺血30min,再灌注30min,经历缺血再灌注损伤过程;(3)SEA0400干预组:在心肌细胞缺血再灌注过程中,予以终浓度1μmol/L的SEA0400进行干预。实验结束后测定以上各组心肌细胞内Ca2+浓度和心肌细胞活力。结果:缺血再灌注可导致心肌细胞活力降低和细胞内Ca2+荧光强度显著升高(P<0.01);SEA0400能够明显增加心肌细胞活力和减轻细胞内Ca2+荧光强度升高(P<0.01)。结论:SEA0400可明显减轻缺血再灌注所致心肌细胞内钙超载,维持心肌细胞活力,从而达到心肌保护的作用。
Objective: To study cardioprotective effects and mechanisms of SEA0400 (2- [4- [(2,5- difluorophenyl)methoxy]-5-ethoxy aniline) on ischemia-reperfusion injury in rat myocytes. Methods: Rat myocyte suspension were obtained from adult rat hearts by Langendorff peffusion and enzymatic dissociation,and randomly divided into three groups including the control group, ischemia-reperfusion injury group and SEA0400 intervention group. The control group was incubated in normal condition for 60 minutes. The ischemia-reperfusion injury group underwent ischemia for 30 minutes and reperfusion for 30 minutes respectively. SEA0400 intervention group underwent the same as ischemia-reperfusion injury group in the presence of 1μmol/L SEA(M00. MTF was applied for the measurement of the cardiomyocyte viability at the end of reperfusion period. The intracellular Ca^2+ concentration was measured by laser scanning confocal microscope (LSCM) and expressed as fluorescence intensity of Fluo-3. Results: Ischemia-reperfusion resulted in the decrease of the cardiomyocyte viability and the increase of the fluorescence intensity of Fluo-3 in rat myocyte. SEA0400 could significantly increase the cardiomyocyte viability and decrease the fluorescence intensity of Fluo-3 in rat myocyte. Conclusion: SEA0400 could attenuate Ca^2+ overload in cardiomyocytes and improve significantly the cardiomyocyte viability during ischemia and reperfusion periods.
出处
《重庆医科大学学报》
CAS
CSCD
北大核心
2010年第1期43-45,共3页
Journal of Chongqing Medical University